Precigen, Inc.
Precigen, Inc. (PGEN) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
pgen · stock forecast · 16 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 16 Wall Street analysts in the past 3 months
Buy
16 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$14.00
Consensus
$14.00
+292.7% upside
Low
$14.00
Median: $14 · Last Close: $3.56
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $3.39 | ↓ 5.00% |
1-day model range: $3.36–$3.41. Peak: $3.41 (-5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · PGEN · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-14 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-05-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-26 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-03-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-19 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2025-08-15 | JP Morgan | Upgrade ↑ | Underweight→Neutral |
| 2025-08-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Precigen, Inc. (PGEN) stock. Of the recent 67 rating actions, 3 were upgrades and 5 were downgrades. 16 analysts currently cover PGEN.
Analyst Recommendation Trends
PGEN analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$124M
↓ 71.6% YoY
Revenue Next Year
$229M
↑ 84.1% YoY
EPS This Year
$-0.03
EPS Next Year
$0.20
↓ 764.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast PGEN EPS of $-0.03 for the current fiscal year, based on estimates from 2 analysts. The PGEN revenue forecast is $124M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The PGEN stock forecast is supported by two independent data sources: analyst consensus ratings from 16 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PGEN price target is $14.00 (+292.7% upside), with an analyst consensus of Buy.
The PGEN short-term stock prediction for tomorrow is $3.39 (-5.00%).
Precigen, Inc. trades on NASDAQ under the ticker PGEN. The PGEN stock outlook for 2027 is broadly positive, supported by a Buy consensus among 69% of covering analysts.
Frequently asked questions
PGEN forecast · 8 questionsAccording to 16 Wall Street analysts, the average 12-month PGEN price target is $14.00, with a high forecast of $14.00 and a low of $14.00. The median price target is shown in the chart above when available. This implies +292.7% potential upside from the current price of $3.56.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.